Arkolith/Insider Trading/TWST/Form 4

Leproust Emily M.

Chief Executive Officer, DirectorTwist Bioscience Corp (TWST) · full profile →Form 4 · filed May 28, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$3.2M
Net Open-Market Flow
-$3.2M
Transactions
7
5 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 27, 2026Sell(S)24K$65.24$1.5M848K
May 27, 2026Option exercise(M)25K$8.82$221K872K
May 27, 2026Sell(S)1K$66.28$84K847K
May 26, 2026Option exercise(M)24K$8.82$214K871K
May 26, 2026Sell(S)24K$65.08$1.6M847K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 27, 2026Option exercise(M)25K—$092K
May 26, 2026Option exercise(M)24K—$0117K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001214659-26-006835) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML